SCHEMBL7563569

SCHEMBL7563569

NNC(=O)c1[nH]c2ccccc2c1Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.61
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 5/20 0.55
NHERF1 O14745 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
HPGD P15428 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
MTNR1A P48039 1/20 0.49
MTNR1B P49286 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
FOLH1 Q04609 1/20 0.48
MAPT P10636 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
EGFR P00533 2/20 0.45
SRC P12931 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6014809 0.91 GAA (0.63) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL7745979 0.85 KDM4E (0.57) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL6756295 0.84 KDM4E (0.65) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL6846657 0.76 GAA (0.65) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL7671532 0.76 HTR6 (0.68) GAAKDM4EALDH1A1HPGDTSHR
SCHEMBL13701155 0.76 KDM4E (0.71) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL7566685 0.76 GAA (1.00) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL7528238 0.75 GAA (0.63) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL7675599 0.75 GAA (0.63) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL7675702 0.75 GAA (0.63) GAAKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 GAA 3668/4885KDM4E 1608/4885ALDH1A1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.